1 in 3 COVID survivors in Rwanda still have symptoms, plus new insights on inflammation and recovery
1 in 3 COVID survivors in Rwanda still have symptoms, plus new insights on inflammation and recovery
New research is painting a clearer picture of long COVID's global reach and biological mechanisms. From Rwanda to Sweden, scientists are uncovering who's most at risk and why some people can't shake persistent symptoms.
π Rwanda Study Reveals Long COVID's Global Impact
A nationally representative survey of 3,143 adult COVID survivors in Rwanda found that 34% still experience persistent symptoms months after infection.
The most common lingering issues were back pain, headache, dizziness, fatigue, and reduced sexual desire
Women, adults over 35, and people with multiple COVID infections had higher odds of long COVID, while those with anxiety were also at increased risk
Surprisingly, COVID vaccination showed no association with long COVID risk in this population
Why this matters: This is one of the first large-scale studies from sub-Saharan Africa, showing long COVID isn't just a problem in wealthy countries. With one-third of survivors affected, healthcare systems worldwide need to prepare for long-term care needs.
Key Findings
π¬ Inflammation During Acute COVID Predicts Long-Term Fatigue
Researchers tracked 54 hospitalized COVID patients and found that specific inflammatory markers during the acute phase predicted who would have chronic fatigue 6-9 months later. Higher levels of IL-1RA, IFN-Ξ³, TNF-Ξ±, and monocyte percentage during the initial infection were linked to increased physical and total fatigue scores later on.
π Anti-Inflammatory Drugs May Prevent Post-COVID Depression
In a study of 588 COVID survivors, those treated with cytokine-blocking drugs (like anakinra and tocilizumab) during their acute illness had less severe depression symptoms and were less likely to develop clinical depression later. The protective effect worked by reducing systemic inflammation, measured by a marker called the systemic inflammation index.
π« Blood Vessel Protein Elevated in Long COVID, Especially Postmenopausal Women
Scientists analyzed 1,395 protein biomarkers in 171 people and discovered that VEGFA, a protein involved in blood vessel function, was significantly overexpressed in long COVID patients. The effect was particularly pronounced in postmenopausal women, suggesting hormonal status plays a role in vascular dysfunction after COVID.
πββοΈ Exercise Capacity Remains Impaired Six Months Later
A study comparing 94 long COVID patients to 100 recovered patients and 70 healthy controls found persistent exercise problems. Long COVID patients had significantly reduced oxygen consumption (70.1% of predicted normal) and walked shorter distances (484 meters vs 607 meters for recovered patients) on a 6-minute walk test. These impairments showed no improvement over six months.
π± Wearable Devices Could Track Fatigue Across Chronic Diseases
A systematic review found that digital biomarkers from wearable devices consistently correlate with fatigue across 13 different chronic conditions, including long COVID, multiple sclerosis, and cancer. Reduced physical activity, increased sedentary behavior, and signs of autonomic nervous system dysfunction were common patterns linked to fatigue levels.
π£οΈ Swedish Experts Divided on Long COVID Diagnosis
Interviews with 36 Swedish healthcare experts revealed significant disagreements about long COVID as a medical diagnosis. While all agreed patients need care, they disagreed on whether it's a unique condition requiring specialized treatment or similar to other post-viral syndromes. Experts also noted concerning demographics: white Swedish women were overrepresented among patients, while migrants and elderly were largely absent from care.
Implications
These studies reveal long COVID as a complex, multi-system condition affecting millions globally, with inflammation and vascular dysfunction as key drivers. The research suggests early intervention with anti-inflammatory treatments might prevent some long-term complications, while highlighting concerning disparities in who receives care and recognition.
Studies in this issue
Primary sources used for this newsletter.
- How common and what features long-term symptoms after COVID-19 have in Rwandamain storyIJID regions2025-10-10PMID 41070108
- Experts' differing views on diagnosing long-term COVID-19 symptoms in Swedenkey findingHealth expectations : an international journal of public participation in health care and health policy2025-10-07PMID 41054864
- Digital signs of fatigue in long-term illnesses: a systematic reviewkey findingNPJ digital medicine2025-10-08PMID 41062803
- Inflammation linked to fatigue after COVID-19key findingBrain, behavior, & immunity - health2025-10-10PMID 41070112
- VEGFA-related patterns linked to ongoing long COVID symptoms differ by sexkey findingBMC medicine2025-10-11PMID 41074076
- Blocking Immune Signals May Reduce Inflammation and Improve Depression After COVID-19key findingJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2025-10-10PMID 41071398
- Breathing and energy limits in people with long COVIDkey findingRespiratory physiology & neurobiology2025-10-11PMID 41075953
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.